Patent · US Active

Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia

US8562968B2 · kind B2 · utility

0Cited by

6References

14Claims

0Family size

Assignee

GSF-Forshungszentrum für Umwelt und Gesundheit, GmbH · DE

Inventors

Wolfgang H. H. Gunther · Hersbruck, DE
Hans Jochen Kolb · Birkenfeld, DE

Key dates

Filing date	Apr 10, 2003
Grant date	Oct 22, 2013
Priority date	—
Expiry date	Apr 17, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of a composition containing stem cells as well as CD6 depleted stem cells for the induction of a tolerance to allogenic transplants and/or for the treatment of blood, immune, and cancer diseases for time-staggered application wherein first the stem cells are applied followed by application of the CD6 depleted stem cells. Furthermore, the present invention relates to a compound preparation containing stem cells and CD6 depleted stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.